- Home
- DNTH vs PACS Comparison
DNTH vs PACS Comparison
Compare DNTH & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNTH | PACS |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.3B |
| IPO Year | 2018 | 2024 |
Fundamental Metrics
Financial Performance| Metric | DNTH | PACS |
|---|---|---|
| Price | $88.51 | $32.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 4 |
| Target Price | ★ $121.00 | $45.50 |
| AVG Volume (30 Days) | 523.2K | ★ 704.5K |
| Earning Date | 05-06-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 221.05 |
| EPS | N/A | ★ 1.22 |
| Revenue | $2,036,000.00 | ★ $5,288,932,000.00 |
| Revenue This Year | N/A | $10.19 |
| Revenue Next Year | $29.48 | $8.58 |
| P/E Ratio | ★ N/A | $27.03 |
| Revenue Growth | N/A | ★ 29.32 |
| 52 Week Low | $16.77 | $7.50 |
| 52 Week High | $96.50 | $43.08 |
Technical Indicators
Market Signals| Indicator | DNTH | PACS |
|---|---|---|
| Relative Strength Index (RSI) | 56.27 | 41.43 |
| Support Level | $33.94 | $29.31 |
| Resistance Level | $96.50 | $36.45 |
| Average True Range (ATR) | 4.02 | 1.46 |
| MACD | -1.21 | -0.20 |
| Stochastic Oscillator | 45.82 | 6.20 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
About PACS PACS Group Inc.
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.